Mackenzie Financial
IRWD icon

Mackenzie Financial’s Ironwood Pharmaceuticals IRWD Stock Holding History

Mackenzie Financial’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.97M Buy
560,034
+548,490
+4,751% +$2.25M ﹤0.01% 933
2025
Q4 		$38.4K Buy
11,544
+1,084
+10% +$2.81K ﹤0.01% 1630
2025
Q3 		$13.7K Hold
10,460
– – ﹤0.01% 1687
2025
Q2 		$7.5K Hold
10,460
– – ﹤0.01% 1690
2025
Q1 		$15.4K Hold
10,460
– – ﹤0.01% 1653
2024
Q4 		$46.3K Hold
10,460
– – ﹤0.01% 1662
2024
Q3 		$43.1K Hold
10,460
– – ﹤0.01% 1544
2024
Q2 		$68.2K Hold
10,460
– – ﹤0.01% 1466
2024
Q1 		$91.1K Hold
10,460
– – ﹤0.01% 1430
2023
Q4 		$120K Sell
10,460
-2,253
-18% -$22.3K ﹤0.01% 1389
2023
Q3 		$123K Buy
12,713
+2,253
+22% +$22.1K ﹤0.01% 1331
2023
Q2 		$109K Hold
10,460
– – ﹤0.01% 1403
2023
Q1 		$110K Hold
10,460
– – ﹤0.01% 1400
2022
Q4 		$130K Buy
+10,460
New +$119K ﹤0.01% 1300
2021
Q1 		– Sell
-45,622
Closed -$520K – 1162
2020
Q4 		$520K Sell
45,622
-48,694
-52% -$533K ﹤0.01% 831
2020
Q3 		$848K Buy
94,316
+21,550
+30% +$214K ﹤0.01% 700
2020
Q2 		$751K Sell
72,766
-344
-0.5% -$3.52K ﹤0.01% 728
2020
Q1 		$738K Buy
73,110
+18,570
+34% +$218K ﹤0.01% 722
2019
Q4 		$726K Buy
+54,540
New +$601K ﹤0.01% 791
2014
Q2 		– Sell
-109,038
Closed -$1.13M – 655
2014
Q1 		$1.13M Buy
109,038
+56,878
+109% +$640K 0.01% 475
2013
Q4 		$507K Hold
52,160
– – ﹤0.01% 581
2013
Q3 		$517K Buy
52,160
+238
+0.5% +$2.33K ﹤0.01% 569
2013
Q2 		$432K Buy
+51,922
New +$629K ﹤0.01% 593

Other funds holding IRWD

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Mackenzie Financial's IRWD Position: Q1 2026 in Review

Mackenzie Financial increased its Ironwood Pharmaceuticals (IRWD) stake by 4,751% in Q1 2026, buying an estimated $2.25M and bringing the position to 560,034 shares worth $1.97M. The position accounts for ﹤0.01% of the portfolio, ranked #933.

Mackenzie Financial first reported a position in IRWD in Q2 2013 and has held it in 23 quarters since. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.

  • Mackenzie Financial held 560,034 shares of Ironwood Pharmaceuticals worth $1.97M as of Q1 2026.
  • Mackenzie Financial bought 548,490 Ironwood Pharmaceuticals shares in Q1 2026, an estimated $2.25M.
  • Ironwood Pharmaceuticals made up ﹤0.01% of Mackenzie Financial's portfolio in Q1 2026, its #933 holding.
  • Mackenzie Financial first reported a position in Ironwood Pharmaceuticals in Q2 2013 and has held it in 23 quarters since.
  • 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.

Based on Mackenzie Financial's 13F filing for Q1 2026, filed 13 May 2026.